Drug laws and licensing

Publications

List of Advisory Council publications

Found 53 publications Showing 1-10

	ACMD register of interests 2009 (02/11/2009) A register of interests for the members of the Advisory Council on the Misuse of Drugs.
	Review of the ACMD (2009) (13/10/2009) In line with Cabinet Office guidelines, the Home Office is commencing a review of two of the department’s non-executive, advisory, non-departmental public bodies (NDPBs), the Advisory Council on the Misuse of Drugs (ACMD) and the Animals Procedures Committee (APC).
	Correspondence to MHRA - Naloxone (18/09/2009) Correspondence to MHRA -Naloxone
	ACMD letter to the Home Secretary on the government's consultation on GBL and 1,4-butanediol (25/08/2009) The ACMD recognise the indisputable harms associated with taking GBL and 1,4-BD.
	ACMD letter to the Home Secretary on the consideration of oripavine (25/08/2009) Oripavine is an alkaloid found in poppy straw (Class A) of the opium poppy.
	ACMD Annual Report 2008-09 (28/07/2009) The Advisory Council on the Misuse of Drugs (ACMD) is a statutory and non-executive Non-Departmental Public Body (NDPB), which was established under the Misuse of Drugs Act 1971.
	ACMD 1-benzylpiperazine (BZP) Report (2008) (21/05/2009) ACMD 1-benzylpiperazine (BZP) Report (2008)
	ACMD open meeting registration form - 14 May 2009 (27/04/2009) Registration form for the Advisory Council on the Misuse of Drugs (ACMD) open meeting, to be held in London on the 14 May 2009.
	ACMD hepatitis C report (2009) (25/02/2009) ACMD hepatitis C report (2009)
	ACMD hepatitis C report - press notice (2009) (25/02/2009) Hepatitis C is a significant public health issue. It has been estimated that in 2003 in England and Wales there were around 190,000 individuals infected with the hepatitis C virus (HCV).

Found 53 items, displaying 1 to 10.

• Page:
• Previous
• 1
• 2
• 3
• 4
• 5
• 6
• Next